The import of pharmaceutical products to Mexico stood at 4.13 billion USD in 2023. The overall trend from 2013 to 2023 shows fluctuating values with notable contractions in 2016 and 2017, followed by a recovery phase from 2018 onwards. The year-on-year variation indicated modest increases in 2020 and 2021, with a slight decline in 2022 and a minor increase of 0.72% in 2023. The compound annual growth rate (CAGR) over the past five years has been 0.28%.
Looking ahead, from 2024 to 2028, the forecasted CAGR is expected to be 0.48%, with an overall growth rate of 2.43% indicating modest growth. Future trends to watch for include technological advancements in pharmaceuticals, regulatory changes, and economic or geopolitical factors that could affect trade and supply chains.
